Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health

PHASE4CompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

April 21, 2008

Primary Completion Date

September 16, 2010

Study Completion Date

September 16, 2010

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rosiglitazone

up to 8mg/day

DRUG

Metformin

up to 2000mg/day

Trial Locations (42)

1425

GSK Investigational Site, Buenos Aires

1810

GSK Investigational Site, Marikina City

12401

GSK Investigational Site, Kingston

13057

GSK Investigational Site, East Syracuse

13415

GSK Investigational Site, Tallinn

13419

GSK Investigational Site, Tallinn

18003

GSK Investigational Site, Granada

18014

GSK Investigational Site, Granada

29201

GSK Investigational Site, Columbia

29204

GSK Investigational Site, Columbia

33143

GSK Investigational Site, Miami

33156

GSK Investigational Site, Miami

34000

GSK Investigational Site, Durango

37660

GSK Investigational Site, Kingsport

40504

GSK Investigational Site, Lexington

54000

GSK Investigational Site, Lahore

62250

GSK Investigational Site, Cuernavaca

64460

GSK Investigational Site, Monterrey

70461

GSK Investigational Site, Slidell

78221

GSK Investigational Site, San Antonio

85745

GSK Investigational Site, Tucson

87102

GSK Investigational Site, Albuquerque

87106

GSK Investigational Site, Albuquerque

89117

GSK Investigational Site, Las Vegas

90022

GSK Investigational Site, Los Angeles

90255

GSK Investigational Site, Huntington Park

90502

GSK Investigational Site, Torrance

92081

GSK Investigational Site, Vista

92117

GSK Investigational Site, San Diego

95823

GSK Investigational Site, Sacramento

97129

GSK Investigational Site, Mérida

98801

GSK Investigational Site, Wenatchee

B1704ETD

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

C1012AAR

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

C1128AAF

GSK Investigational Site, Buenos Aires

V6H 3X8

GSK Investigational Site, Vancouver

L6T 3T1

GSK Investigational Site, Brampton

J2G 8Z9

GSK Investigational Site, Granby

01008

GSK Investigational Site, Manila

03114

GSK Investigational Site, Alicante

03503

GSK Investigational Site, Benidorm/Alicante

03610

GSK Investigational Site, Petrel

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY